Indefinite Delivery Contract SPE2DB24D9155

This single-award indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $4,999,999.00 contract, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

The IDC enables DMS Pharmaceutical Group to provide a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical requirements of military personnel and their dependents across various DoD healthcare facilities. The contract covers a wide variety of items such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications, as well as surgical lubricants, ophthalmic solutions, and generic drugs across multiple therapeutic classes. The period of performance runs through December 31, 2025, complementing DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites.